Hematopoietic Stem Cell TransplantationHematopoietic Stem CellsStem CellsTransplantation, HomologousStem Cell TransplantationPeripheral Blood Stem Cell TransplantationBone MarrowTransplantation, AutologousBone Marrow TransplantationBone Marrow CellsGraft vs Host DiseaseTransplantation ConditioningHematologic NeoplasmsHematopoietic Stem Cell MobilizationCord Blood Stem Cell TransplantationHematopoiesisAntigens, CD34Transplantation ChimeraEmbryonic Stem CellsCell DifferentiationAdult Stem CellsTissue DonorsGraft SurvivalTreatment OutcomeWhole-Body IrradiationBusulfanStem Cell NicheGranulocyte Colony-Stimulating FactorMesenchymal Stem Cell TransplantationHistocompatibility TestingLeukemiaHistocompatibilityMyeloablative AgonistsCell LineagePluripotent Stem CellsMultiple MyelomaCombined Modality TherapyRecurrenceBone and BonesColony-Forming Units AssayRetrospective StudiesMelphalanFlow CytometryMice, Inbred C57BLStem Cell FactorRemission InductionCyclophosphamideMultipotent Stem CellsChimerismGraft vs Leukemia EffectMesenchymal Stromal CellsCells, CulturedBone Marrow DiseasesTime FactorsLeukapheresisNeural Stem CellsLeukemia, Myeloid, AcuteHematologic DiseasesInduced Pluripotent Stem CellsFetal BloodImmunosuppressive AgentsMyelodysplastic SyndromesCell SeparationAnemia, AplasticLiver TransplantationVidarabineSurvival RateAntineoplastic Combined Chemotherapy ProtocolsDisease-Free SurvivalHLA AntigensHepatic Veno-Occlusive DiseaseSurvival AnalysisCell ProliferationCell TransplantationTransplantation, IsogeneicBone Marrow PurgingSiblingsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveUnrelated DonorsBlood CellsBlood Component RemovalGraft vs Tumor EffectLymphoma, Non-HodgkinPrecursor Cell Lymphoblastic Leukemia-LymphomaTransplantation ImmunologyLymphocyte TransfusionFetal Stem CellsBone Marrow ExaminationSalvage TherapyBlood Cell CountT-LymphocytesSevere Combined ImmunodeficiencyLymphocyte DepletionCell Culture TechniquesCytomegalovirus InfectionsMice, SCIDAcute DiseaseAntigens, CDFollow-Up StudiesImmunophenotyping